• Dobrzycka B, Terlikowski SJ, Kowalczuk O, Kulikowski M, Niklinski J. Serum levels of VEGF and VEGF-C in patients with endometrial cancer. Eur Cytokine Netw. 2011 Mar;22(1):45-51.
• Lapinski TW, Flisiak R, Jaroszewicz J, Michalewicz M, Kowalczuk O. Efficiency and safety of lamivudine therapy in patients with chronic HBV infection, dialysis or after kidney transplantation. World J Gastroenterol. 2005 Jan 21;11(3):400-2.
• Niklinski J, Niklinska W, Chyczewska E, Laudanski J, Naumnik W, Chyczewski L, Pluygers E. The epidemiology of asbestos-related diseases. Lung Cancer. 2004 Aug;45 Suppl 1:S7-S15.
• Niklinski J, Hirsch FR. Molecular approaches to lung cancer evaluation. Lung Cancer. 2002 Dec;38 Suppl 3:S9-17.
• Niklinski J, Laudanski J, Chyczewski L, Jassem J, Fischer JR, Manegold Ch. International conference on 'Non Small Cell Lung Cancer: Standards and New Trends in Diagnosis and Therapy', October 5-7, 2001, medical academy of Bialystok, Bialystok, Poland. Lung Cancer. 2002 Jul;37(1):109-12.
• Niklińska W, Burzykowski T, Chyczewski L, Nikliński J. Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis. Lung Cancer. 2001 Dec;34 Suppl 2:S59-64.
• Nikliński J, Niklińska W, Laudanski J, Chyczewska E, Chyczewski L. Prognostic molecular markers in non-small cell lung cancer. Lung Cancer. 2001 Dec;34 Suppl 2:S53-8. Review.
• Niklinski J, Niklinska W, Chyczewski L, Becker HD, Pluygers E. Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. Eur J Cancer Prev. 2001 Jun;10(3):213-26.
• Mroczko B, Szmitkowski M, Niklinski J. Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer. Clin Chem Lab Med. 2001 May;39(5):374-9.
• Laudanski J, Niklinska W, Burzykowski T, Chyczewski L, Niklinski J. Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell  lung cancer. Eur Respir J. 2001 Apr;17(4):660-6.
• Chyczewski L, Niklińska W, Naumnik W, Chyczewska E, Nikliński J. P16INK4a point mutations and promoter hypermetylation in bronchial preneoplastic lesions. Folia Histochem Cytobiol. 2001;39 Suppl 2:33-5.
• Niklinska W, Chyczewski L, Laudanski J, Chyczewska E, Niklinski J. Detection of p16 abnormalities in early-stage non-small cell lung cancer. Folia Histochem Cytobiol. 2001;39 Suppl 2:30-2.
• Juczewska M, Chyczewska E, Naumnik W, Chyczewski L, Niklińska W, Rogalewska A, Kovalchuk O, Nikliński J. Endothelial cells and angiogenesis intensity in lung cancer. Folia Histochem Cytobiol. 2001;39(3):253-8.
• Niklinska W, Chyczewski L, Niklinski J. New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies. Folia Histochem Cytobiol. 2001;39(2):99-103.
• Niklinska W, Burzykowski T, Laudanski J, Chyczewska E, Chyczewski L, Niklinski J. Strong association between P53 protein accumulation, serum antibodies and gene mutation in non-small cell lung cancer. Folia Histochem Cytobiol. 2001;39(2):51-6.
• Niklinska W, Chyczewski L, Laudanski J, Sawicki B, Niklinski J. Detection of P53 abnormalities in non-small cell lung cancer by yeast functional assay. Folia Histochem Cytobiol. 2001;39(2):147-8.
• Niklinska W, Laudanski J, Niklinski J. G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview. Neoplasma. 2001;48(3):157-63.
• Niklinski J, Claassen G, Meyers C, Gregory MA, Allegra CJ, Kaye FJ, Hann SR, Zajac-Kaye M. Disruption of Myc-tubulin interaction by hyperphosphorylation of c-Myc during mitosis or by constitutive hyperphosphorylation of mutant c-Myc in Burkitt's lymphoma. Mol Cell Biol. 2000 Jul;20(14):5276-84.
• Niklinska W, Burzykowski T, Chyczewski L, Rusin MR, Furman M, Laudanski J, Chyczewska E, Sulik M, Niklinski J. p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland. Eur J Cancer Prev. 2000 Apr;9(2):81-7.